Boston, MA -- (SBWire) -- 08/07/2012 --Global Market Direct's pharmaceuticals report, "ACT Biotech, Inc. - Product Pipeline Review - 2012" provides data on the ACT Biotech, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, ACT Biotech, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from ACT Biotech, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.
View Full Report Details and Table of Contents
Scope
- ACT Biotech, Inc. - Brief ACT Biotech, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ACT Biotech, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of ACT Biotech, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the ACT Biotech, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to Get this Report
- Evaluate ACT Biotech, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of ACT Biotech, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the ACT Biotech, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with ACT Biotech, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of ACT Biotech, Inc. and identify potential opportunities in those areas.
Companies Mentioned in this Report: ACT Biotech, Inc.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- ACT Biotech, Inc. - Product Pipeline Review - H2 2011
- Aduro BioTech - Product Pipeline Review - 2012
- Digna Biotech, S.L. - Product Pipeline Review - 2012
- ACT Biotech, Inc. - Product Pipeline Review - Q1 2011
- Bharat Biotech International Limited - Product Pipeline Review - 2012
- Kenta Biotech Ltd. - Product Pipeline Review - 2012
- Fresenius Biotech GmbH - Product Pipeline Review - 2012
- Indus Biotech Private Limited - Product Pipeline Review - 2012
- SBI Biotech Co., Ltd. - Product Pipeline Review - 2012
- Bayer AG - Product Pipeline Review - 2012
"ACT Biotech, Inc. - Product Pipeline Review - 2012" Now Available at Fast Market Research
New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research